• Profile
Close

Intraductal carcinoma of the prostate in the absence of high-grade invasive carcinoma represents a molecularly distinct type of in situ carcinoma enriched with oncogenic driver mutations

Journal of Pathology Jun 01, 2019

Khani F, et al. - Because intraductal carcinoma of the prostate (IDC-P) most often seems to be related to high-grade invasive prostate carcinoma (PCa), where it is believed to be a retrograde spread, however, IDC-P rarely occurs as an isolated finding in radical prostatectomy or concurrent low-grade (Grade Group 1) invasive carcinoma, investigators hypothesized that in these unusual cases isolated IDC-P (iIDC-P) may represent a distinct in situ lesion and molecularly profiled 15 cases. Findings revealed that iIDC-P is enriched with potentially targetable oncogenic driver mutations in MAPK/PI3K genes despite a copy number alteration profile similar to conventional PCa. Based on the status of PTEN and ERG, iIDC-P is unlikely to be a precursor to the associated low-grade invasive PCa, but is an unclear clinical significance molecularly unique in situ tumor.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
  • Exclusive Write-ups & Webinars by KOLs

  • Nonloggedininfinity icon
    Daily Quiz by specialty
  • Nonloggedinlock icon
    Paid Market Research Surveys
  • Case discussions, News & Journals' summaries
Sign-up / Log In
x
M3 app logo
Choose easy access to M3 India from your mobile!


M3 instruc arrow
Add M3 India to your Home screen
Tap  Chrome menu  and select "Add to Home screen" to pin the M3 India App to your Home screen
Okay